Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Return on Equity (2019 - 2025)

Historic Return on Equity for TransMedics (TMDX) over the last 7 years, with Q3 2025 value amounting to 0.27%.

  • TransMedics' Return on Equity rose 1100.0% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.19% for FY2024, which is 3500.0% up from last year.
  • TransMedics' Return on Equity amounted to 0.27% in Q3 2025, which was up 1100.0% from 0.25% recorded in Q2 2025.
  • TransMedics' 5-year Return on Equity high stood at 0.27% for Q3 2025, and its period low was 0.86% during Q2 2022.
  • Over the past 5 years, TransMedics' median Return on Equity value was 0.19% (recorded in 2023), while the average stood at 0.19%.
  • As far as peak fluctuations go, TransMedics' Return on Equity tumbled by -5400bps in 2022, and later skyrocketed by 7600bps in 2023.
  • TransMedics' Return on Equity (Quarter) stood at 0.61% in 2021, then surged by 68bps to 0.19% in 2022, then grew by 1bps to 0.19% in 2023, then skyrocketed by 184bps to 0.16% in 2024, then surged by 68bps to 0.27% in 2025.
  • Its last three reported values are 0.27% in Q3 2025, 0.25% for Q2 2025, and 0.2% during Q1 2025.